Publications by authors named "Athanasios Mavratzas"

Claim this Profile
I
Impact of Adding Aromatherapy to Sound Intervention on Cardiovascular Parameters and Psychophysiological Measures in Cancer Patients: A Randomized Exploratory Trial.
Anna Lena Hohneck, Melissa Troia, Valentin Kolar, Simone Weingärtner, Kirsten Merx, Athanasios Mavratzas

Oncol Res Treat· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential effects of sound interventions tuned to 432 Hz or 443 Hz on cardiovascular parameters in cancer patients: a randomized cross-over trial.
Anna Hohneck, Ánxelo Maia Rodríguez, Simone Weingärtner, Kirsten Merx, Felicitas Sarodnick, Athanasios Mavratzas

BMC Complement Med Ther· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of a Sound Intervention on Physical and Emotional Well-Being in Patients with Cancer: A Prospective Randomized Trial.
Anna Hohneck, Rosa Meissner, Christina Reyser, Lara Heinemann, Kathrin Christians, Athanasios Mavratzas

Oncol Res Treat· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic Value of sST2, VCAM-1, and Adiponectin in Patients with Breast Cancer to Predict Anti-Tumour Treatment-Related Cardiac Events: A Pilot Study.
Stephanie Luise Rosenkaimer, Laura Winter, Tina Sieburg, Sandra Maier, Athanasios Mavratzas

Oncol Res Treat· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse Cardiovascular Effects of Anti-tumor Therapies in Patients With Breast Cancer: A Single-center Cross-sectional Analysis.
Stephanie Rosenkaimer, Tina Sieburg, Laura Winter, Athanasios Mavratzas, Wolf-Karsten Hofmann

Anticancer Res· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CATCH: A Prospective Precision Oncology Trial in Metastatic Breast Cancer.
Mario Hlevnjak, Markus Schulze, Shaymaa Elgaafary, Carlo Fremd, Laura Michel, Athanasios Mavratzas

JCO Precis Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential Effects of Sound Intervention and Rest on Cardiovascular Parameters in Cancer Patients: A Randomized Cross-over Trial.
Anna Hohneck, Christina Reyser, Kirsten Merx, Simone Weingärtner, Athanasios Mavratzas

Integr Cancer Ther· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 Trial of Oncolytic H-1 Parvovirus Therapy Shows Safety and Signs of Immune System Activation in Patients With Metastatic Pancreatic Ductal Adenocarcinoma.
Jacek Hajda, Barbara Leuchs, Assia L Angelova, Veronika Frehtman, Jean Rommelaere, Athanasios Mavratzas

Clin Cancer Res· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of Luminal Metastatic Breast Cancer beyond CDK4/6 Inhibition: Is There a Standard of Care in Clinical Practice?
Athanasios Mavratzas, Frederik Marmé

Breast Care (Basel)· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alpelisib in the treatment of metastatic HR+ breast cancer with mutations.
Athanasios Mavratzas, Frederik Marmé

Future Oncol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Completion rate and impact on physician-patient relationship of video consultations in medical oncology: a randomised controlled open-label trial.
Thomas Walle, Erkin Erdal, Leon Mühlsteffen, Hans Martin Singh, Editha Gnutzmann, Athanasios Mavratzas

ESMO Open· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Checkpoint Blockade in Patients with Triple-Negative Breast Cancer.
Laura L Michel, Alexandra von Au, Athanasios Mavratzas, Katharina Smetanay, Florian Schütz

Target Oncol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atezolizumab for use in PD-L1-positive unresectable, locally advanced or metastatic triple-negative breast cancer.
Athanasios Mavratzas, Julia Seitz, Katharina Smetanay, Andreas Schneeweiss, Dirk Jäger

Future Oncol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Humanized Anti-CD22-Onconase Antibody-Drug Conjugate Mediates Highly Potent Destruction of Targeted Tumor Cells.
Tobias Weber, Athanasios Mavratzas, Stefan Kiesgen, Stephanie Haase, Benedikt Bötticher

J Immunol Res· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-level production of a humanized immunoRNase fusion protein from stably transfected myeloma cells.
Jürgen Krauss, Evelyn Exner, Athanasios Mavratzas, Siegfried Seeber, Michaela A E Arndt

Methods Mol Biol· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis